Related Experiment Video
Updated: May 16, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Can mean platelet volume be a new risk factor in portal venous thrombosis?
Ibrahim Aliosmanoglu1, Mesut Gul, Abdullah Oguz
1Department of General Surgery, Dicle University, Diyarbakır, Turkey. ialiosman@gmail.com
Background:
The aim of this study was to discuss the possibility of mean platelet volume (MPV) being a new risk factor in the etiology of portal venous thrombosis (PVT).
Methods:
Study participants were categorized into 2 different groups: group I, control group (n = 35) and group II, PVT group (n = 34). Demographic data and MPV values were recorded retrospectively.
Results:
No differences were determined between the 2 groups regarding hypertension, diabetes mellitus, and smoking (P > .05). The average hemoglobin levels were 10.8 ± 2.1 in group II and 14.0 ± 1.7 in group I (P < .001). Although the MPV levels of group II patients were 8.2 ± 0.52, the average level in group I was determined as 7.8 ± 0.62 (P = .012). In the performed receiver-operating characteristic (ROC) analysis, the cutoff value for patients with PVT for MPV was determined as 7.9 (area under curve: 0.674), sensitivity as 70.6%, and specificity as 65.7% (P = .013).
Conclusion:
The current study shows that MPV is significantly higher in patients with PVT than in the control group.
Insights
Mean platelet volume (MPV) is significantly higher in patients with portal venous thrombosis (PVT). This finding suggests MPV may serve as a novel risk factor for PVT development.
Area of Science:
- Hepatology
- Hematology
- Thrombosis Research
Background:
- Investigating novel risk factors for portal venous thrombosis (PVT) is crucial for early detection and management.
- Mean platelet volume (MPV) has emerged as a potential biomarker in various vascular conditions.
Purpose of the Study:
- To evaluate the potential of mean platelet volume (MPV) as a new risk factor in the etiology of portal venous thrombosis (PVT).
Main Methods:
- Retrospective analysis of demographic data and MPV values in 34 PVT patients and 35 controls.
- Comparison of MPV levels between the PVT group and the control group.
- Receiver-operating characteristic (ROC) curve analysis to determine MPV cutoff value for PVT prediction.
Main Results:
- No significant differences in hypertension, diabetes mellitus, or smoking between groups.
- Significantly lower hemoglobin levels in the PVT group (10.8 ± 2.1) compared to controls (14.0 ± 1.7).
- Significantly higher MPV levels in the PVT group (8.2 ± 0.52) versus controls (7.8 ± 0.62). ROC analysis indicated an MPV cutoff of 7.9 for PVT detection with 70.6% sensitivity and 65.7% specificity.
Conclusions:
- Mean platelet volume (MPV) is significantly elevated in patients diagnosed with portal venous thrombosis (PVT).
- MPV demonstrates potential as a predictive biomarker for identifying individuals at risk of developing PVT.
Related Concept Videos
Portal Hypertension
Venous Thrombosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Esophageal Varices-I: Introduction
Venous Thrombosis IV: Nursing Management

